Underwriting TRANSACTIONAL

We represent the world's leading investment banking firms in initial public offerings, follow-on public offerings, PIPE (private investment in public equity) placements, cross-border offerings, Rule 144A transactions and other private placements. Our extensive experience ranges from IPOs by emerging companies to private offerings of sophisticated debt instruments by established public companies. Our lawyers understand the unique demands of complicated securities transactions. We help our clients plan and complete the offering process effectively and efficiently.

Technology and Life Sciences: Understanding the Subject Matter

We represent a vast array of companies in the information technology, telecommunications, electronics, pharmaceuticals and medical devices industries. More than 160 of our lawyers hold scientific or technical degrees in addition to their law degrees, and many have professional experience in science and technology fields in addition to their legal experience. Because technology is a firm-wide focus, we regularly work with technology and life sciences companies in virtually every area of the law. No other firm is as well positioned to quickly grasp the subject matter and execute a deal that works from the start.

Experience Representing Issuers: Knowing What the Issuer is Thinking

We have a comprehensive understanding of the priorities and expectations of issuers based on thousands of public and private offerings. This experience greatly benefits our investment banking clients in anticipating problems and shaping and exceeding the expectations of issuers. Also, because we are continually engaged in the market for public and private offerings from both perspectives, we understand the business and financial terms that are viewed as reasonable or unreasonable at any given time. This means more time spent getting the deal done and less time wasted in seeking unreasonable, inappropriate or outdated deal terms.

Initial Public Offerings: Bringing Order to Chaos

An IPO is typically the most traumatic and chaotic event in a company’s life span. From the initial organizational meeting, we help plan and shape the offering process to eliminate delay and inefficiency. Our intellectual property, labor and employment and tax lawyers perform valuable due diligence and other offering-related services, eliminating the expense and delay of retaining outside counsel (who often have little or no offering experience) in these areas. Leveraging our technical, market and legal experience, we drive the public offering process for our investment banking clients from the initial planning stages through due diligence and drafting and on to a successful closing.

Follow-On Public Offerings: Complicated, Creative, Fast

Major investment banks retain us in every kind of follow-on public offering, from underwritten offerings with road shows to overnight "bought" public offerings. We have worked on offerings of numerous types of securities, including common stock, perpetual preferred stock, convertible preferred stock, convertible debentures, original issue discount notes, secured notes and straight debt instruments. Our experience with these securities and our sophisticated understanding of the particular requirements of different follow-on offerings allow us to effectively and efficiently represent our investment banking clients in the full range of follow-on public offerings.

Cross-Border Offerings: International Scope

WilmerHale is a recognized leader in international securities transactions, reflecting the combination of our US offerings practice and our extensive experience with cross-border securities, tax and corporate considerations. We advise US and non-US issuers, investment banks and mutual funds on public offerings, private placements and multiple stock exchange listings in the world’s leading capital markets. We have handled over 30 public offerings involving non-US listings or issuers on the London, Frankfurt, Toronto, Paris, Amsterdam, Zurich, Copenhagen, Oslo and Stockholm stock exchanges, as well as numerous ADR and ADS listings on Nasdaq and the New York Stock Exchange.

Private Offerings: Initial Purchasers and Placement Agents

We represent initial purchasers and placement agents in all types of private offerings. We have represented major investment banks in numerous complex Rule 144A and Regulation S offerings of convertible debentures, high-yield bonds and other equity and debt securities. We are experienced in representing placement agents in innovative PIPE offerings. We also represent leading investment banks in large private placements by emerging technology company clients that require significant pre-IPO financing. We collaborate on the preparation of disclosure documents, indentures and deposit, purchase and registration rights agreements. Our experience with the full range of private offerings enables us to handle complicated and time-sensitive transactions quickly and effectively.

Regulatory Issues: Avoiding the Pitfalls

We have significant experience regarding the various regulatory bodies and schemes that impact securities offerings, including the SEC, the NASD, Regulation M and state securities laws. Regulatory issues can disrupt or delay an offering and create potential liability for issuers and our investment banking clients. We help navigate the complicated, shifting regulatory requirements and work with staff attorneys at the SEC and the NASD to resolve difficult offering-related issues. Our lawyers include former senior staff members from the SEC—such as the former Directors of the SEC's Divisions of Enforcement and Investment Management—who provide a wealth of regulatory insight. Our blue sky practitioners handle the chore of state securities law compliance quickly and efficiently. Our working understanding of the regulatory agencies is critical to the offering process and an invaluable aid to getting offerings done.

We represent the world's leading investment banking firms in initial public offerings, follow-on public offerings, PIPE (private investment in public equity) placements, cross-border offerings, Rule 144A transactions and other private placements. Our extensive experience ranges from IPOs by emerging companies to private offerings of sophisticated debt instruments by established public companies. Our lawyers understand the unique demands of complicated securities transactions. We help our clients plan and complete the offering process effectively and efficiently.

Technology and Life Sciences: Understanding the Subject Matter

Read More

Leadership

Sort By
Borden, Mark G.

Mark G. Borden

Chair, Corporate Practice Group

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Salhus, Knute J.

Knute J. Salhus

Co-Chair, Public Company Counseling Group

+1 212 230 8805 (t)

knute.salhus@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 781 966 2027 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Publications & News

View

May 6, 2013

2013 IPO Report

Our 2013 IPO Report offers a detailed analysis of, and outlook for, the IPO market. The report features regional breakdowns, a Q&A with former SEC Corp Fin Director Meredith Cross, and a discussion of the use of social media for investor communications under Regulation FD. We review the elements of relief being chosen by emerging growth companies under the JOBS Act; offer practical insight on “test-the-waters” communications and scheduling the first annual meeting of stockholders; summarize IPO disclosure requirements applicable to directors, officers, 5% stockholders and selling stockholders; discuss Form 10 IPOs as an alternative route to going public; and present useful IPO market metrics that are ordinarily unavailable elsewhere.

May 6, 2013

2013 Corporate Reports

WilmerHale’s annual IPO, Venture Capital and M&A Reports provide comprehensive statistics and analysis that are hard to find elsewhere.

April 17, 2013

Selected 2013 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

September 5, 2012

SEC Proposes Rules to Eliminate the Prohibition Against General Solicitation and General Advertising for Rule 506 and Rule 144A Offerings

August 31, 2012

The 2013 Best Lawyers in America® List Includes 101 WilmerHale Lawyers

June 7, 2012

Chambers USA 2012 Final Results Announced

June 6, 2012

Selected 2012 Life Sciences Transactions

For more than four decades, we have represented life sciences clients in venture financings, public offerings, mergers and acquisitions, and licensing agreements and collaborations; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise-critical patent litigation; and navigated regulatory issues vital to their success.

June 4, 2012

2012 IPO Report

March 27, 2012

Congress Passes New Capital Formation Legislation

October 21, 2011

2011 IPO Report